$BTCY News
Last published 9mo ago
- 9mo agoBTCYBiotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDAGlobeNewswireREDWOOD CITY, CA, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), an innovative Technology-as-a-Service (TaaS) company committed to transforming chronic
- 9mo agoBTCYBiotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11thGlobeNewswireCompany continues to drive Revenue Growth, Margin Strength, Operational Efficiency, and continued positive EBITDA REDWOOD CITY, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an innovative
- 12mo agoBTCYBiotricity Strengthens Path to Scalable Profitability with Sustained Margins & Operational Efficiency in Second Quarter Fiscal 2026GlobeNewswireREDWOOD CITY, CA, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), an innovative Technology-as-a-Service (TaaS) company committed to redefining the landscape
- 1y agoBTCYBiotricity to Host Fiscal 2026 Second Quarter Financial Results and Business Update Call on November 14thGlobeNewswireREDWOOD CITY, CA, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), an innovative Technology-as-a-Service (TaaS) company committed to redefining the landscape
- 1y agoBTCYBiotricity and B-Secur Target the Consumer Wearables Market with Expansion of Next-Gen Cardiac Monitoring PlatformGlobeNewswireREDWOOD CITY, Calif./BELFAST, Northern Ireland, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an innovative medical technology company specializing in remote cardiac monitoring solutions, and
- 1y agoBTCYBiotricity Reinforces Growth Trajectory, Kicking Off Fiscal 2026 with Strong First Quarter Results Featuring Revenue Growth, Positive EBITDA and Improved MarginsGlobeNewswireREDWOOD CITY, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), an innovative Technology-as-a-Service (TaaS) company committed to redefining the landscape
- 1y agoBTCYBiotricity to Host Fiscal 2026 First Quarter Financial Results and Business Update Call on August 14thGlobeNewswireCompany to announce continued Revenue Growth, Improvements in Margins, Operational Efficiency, and a shift to positive EBITDA REDWOOD CITY, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an
- 1y agoBTCYBiotricity Delivers Strong Fiscal Year 2025 Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses, Putting Profitability within ReachGlobeNewswireFY25 revenue up 14.3% YOYFY25 margins improvement of 8.9% to 76.6%, from 69.3% in the prior year; Q4-FY25 margins improved to 80.4% as margin expansion forecasted to continueFY25 operating expenses lower by 24.5%
- 1y agoBTCYBiotricity to Host Fiscal 2025 Fourth Quarter Financial Results and Business Update Call on July 18thGlobeNewswireCompany to announce improvements in Margins, Operational Efficiency, and a shift to positive Adjusted EBITDA REDWOOD CITY, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an innovative
- 1y agoBTCYBiotricity Recognized by Financial Times as One of 2025's Fastest-Growing Companies in the Americas, Growing 256.4% Over the Period AnalyzedGlobeNewswireREDWOOD CITY, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) a leading Technology-as-a-Service (Taas) company specializing in cutting-edge diagnostic and chronic disease management solutions
- 1y agoBTCYBiotricity Expands IP Portfolio & Strategy with 14 New Patents, Reinforcing Innovation & Leadership in Remote Monitoring, Diagnostics, & Chronic Disease ManagementGlobeNewswireBiotricity's latest patents focus on a multi-biometric device platform that functions as both a patch and watch, advancing biometric monitoring solutions for remote patient care. REDWOOD CITY, Calif., March 12, 2025
- 1y agoBTCYBiotricity Delivers Record Margins, Record Revenues, and Record Cashflows with 21.7% Year-Over-Year Sales Growth for its Third Quarter of Fiscal 2025GlobeNewswireCompany reports Q3-FY25 revenue grew by 21.7% YOY to $3.6 millionManagement continues to drive revenues and efficienciesCompany achieved positive cash flow on current operating basis, before paying interest, dividends
- 1y agoBTCYBiotricity Announces Cashflow Breakeven with Biggest Quarter in History and a Revenue Increase of 11%GlobeNewswireCompany expects to report Q3-FY25 revenue growth of 22% from the corresponding prior year quarter to $3.6 million – an 11% increase sequentially from the immediately preceding quarterManagement continues to drive
- 1y agoBTCYBiotricity Achieves Improved Margins and Efficiencies, and Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2025GlobeNewswireCompany achieved positive cash flow in September on a current operating basis, before paying interest, dividends and amortization; management expects to continue to see cash flows improveCompany reports Q2-FY25 revenue
- 1y agoBTCYBiotricity to Host Second Quarter Fiscal Year 2025 Financial Results and Business Update Call on November 15thGlobeNewswireCompany to announce improvements in Margins, Operational Efficiency, and a shift to positive Adjusted EBITDA REDWOOD CITY, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an innovative
- 2y agoBTCYLOBOLOBO EV and Nexalin Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVACCESS NewswireORLANDO, FL / ACCESSWIRE / July 26, 2024 / RedChip Companies will air interviews with LOBO EV Technologies Ltd. and Biotricity, Inc. on the RedChip Small Stocks, Big Money™ show, a
- 2y agoBTCYBiotricity Announces Continued Margin Improvement Driven by its Proprietary AI CloudACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / July 22, 2024 / Biotricity Inc. , a Technology-as-a-Service company operating in the remote cardiac monitor sector of consumer healthcare, today announced ongoing
- 2y agoBTCYENLVEnlivex Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVACCESS NewswireORLANDO, FL / ACCESSWIRE / July 19, 2024 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. and Biotricity, Inc. on the RedChip Small Stocks, Big Money™ show, a
- 2y agoBIAFBTCYBiotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVACCESS NewswireORLANDO, FL / ACCESSWIRE / July 12, 2024 / RedChip Companies will air interviews with Biotricity, Inc. and bioAffinity Technologies, Inc. on the RedChip Small Stocks, Big Money™ show, a
- 2y agoBTCYBiotricity Announces Accelerated Path to EBITDA PositiveACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / July 11, 2024 / Biotricity Inc. , a Technology-as-a-Service company operating in the remote cardiac monitor sector of consumer healthcare, today announced its
- 2y agoBTCYBiotricity Adds 60-Site, Multi-State Hospital Cardiac Monitoring Pilot ProgramACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / July 10, 2024 / Biotricity Inc. , a Technology-as-a-Service company operating in the remote cardiac monitor sector of consumer healthcare, today announced the launch of
- 2y agoBTCYBiotricity Launches HeartSecure: Immediate, At-Home Cardiac Screening Now AvailableACCESS NewswireDemocratizing cardiac health with convenient, rapid, and reliable results REDWOOD CITY, CA / ACCESSWIRE / June 28, 2024 / Biotricity Inc. , a forerunning Technology-as-a-Service company committed to
- 2y agoBTCYBiotricity, Inc. (BTCY) Q4 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoBTCYBiotricity Reports Strong Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses for Fiscal Year 2024, Accelerating the Company's Path to ProfitabilityACCESS NewswireFY24 revenue up 25.2% YOYFY24 margins improved 1280 basis points to 69.3%, from 56.5% in the prior year; Q4-FY24 margins improved to 71.5%; margin expansion forecasted to continueFY24 operating expenses lower by 17.6%
- 2y agoBTCYBiotricity to Host Fourth Quarter and Fiscal Year 2024 Financial Results and Business Update Call on June 27ACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / June 26, 2024 / Biotricity Inc. , a Technology-as-a-Service company operating in the remote cardiac monitor sector
- 2y agoBTCYBiotricity Launches Direct-to-Consumer Heart Health Screening Service, HeartSecure, Making Heart Health Services Accessible in Response to the #1 Global Killer, Poising Company to Access the Growing Home Diagnostics MarketACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / June 12, 2024 / Biotricity Inc. , a forerunning Technology-as-a-Service company committed to disrupting the healthcare industry with cutting-edge medical and consumer
- 2y agoBTCYBiotricity Provides Year-End Guidance with Expectations to Meet Analyst Revenue Target and Beating Loss and Margin TargetsACCESS NewswireCompany expects Loss from Operations to decrease by over 40% YoY and Margin Improvement by over 10% YoYREDWOOD CITY, CA / ACCESSWIRE / June 6, 2024 / Biotricity Inc. , a leading Technology-as-a-Service
- 2y agoBTCYBiotricity Preferred Shareholders Show Increased Commitment and Support of the Company by Converting Almost All Preferred A Shares into Restricted Common StockACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / June 4, 2024 / Biotricity Inc.] , a leading Technology-as-a-Service company dedicated to disrupting the healthcare industry with cutting-edge medical and consumer
- 2y agoBTCYBiotricity Announces the Upcoming Launch of the First-Ever Direct-to-Patient Cardiac Screening Service, Targeting the $1.05B Home Heart Health MarketACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / May 30, 2024 / Biotricity Inc. , a leading Technology-as-a-Service company dedicated to disrupting the healthcare industry with cutting-edge medical and consumer
- 2y agoBTCYBiotricity's Path Towards Breakeven Accelerated by Latest Diagnostic Product, Biotres Pro, Garnering Rapid Interest from Existing and New CustomersACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / April 26, 2024 / Biotricity Inc. , a pioneering Technology-as-a-Service company dedicated to delivering top-of-the-line medical diagnostic and consumer healthcare
- 2y agoBTCYBiotricity Launches Major Cardiac Monitoring Pilot Program in a Hospital System Comprised of 9 Hospitals and 10 ClinicsACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / April 18, 2024 / Biotricity Inc. a leading Technology-as-a-Service company at the forefront of medical diagnostics and consumer healthcare, announces a groundbreaking
- 2y agoBTCYBiotricity Launches Cardiac Monitoring Pilot Program with Major Hospital NetworkACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / April 16, 2024 / Biotricity Inc. , a leading Technology-as-a-Service company revolutionizing the medical diagnostic
- 2y agoBTCYBiotricity Announces a Strategic Partnership for Cardiac Screenings in Patients with Co-MorbiditiesACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / April 2, 2024 / Biotricity Inc. , a leading Technology-as-a-Service company revolutionizing the medical diagnostic
- 2y agoBTCYBiotricity Accelerates Market Access by Partnering with Third Major Group Purchasing Organization, Expanding Market Reach to 90% of U.S. HospitalsACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / March 28, 2024 / Biotricity Inc. , a leading Technology-as-a-Service company revolutionizing the medical diagnostic
- 2y agoBTCYBiotricity Partners with Health Aid Africa to Provide Complementary Heart Health Screenings at Allegiant Stadium ConcertACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / March 21, 2024 / Biotricity Inc. , a leading Technology-as-a-Service company revolutionizing the medical diagnostic
- 2y agoBTCYBiotricity Unveils that Improved Margins Resulted from Latest Advancements to its Proprietary Cardiac AI Cloud Platform and Announces Plans for Continued Expansion of its Cardiac AI CloudACCESS NewswireBiotricity's AI automation engine has already proven to increase operational efficiency and support growth, evidenced by the Company's recent margin improvementThe Healthcare AI Market is projected to soar to $208.2
- 2y agoBTCYBiotricity Partners with a Second Top Group Purchasing Organization - Positions Company for Expanded Market Access to 1 out of every 2 Hospitals in AmericaACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / March 5, 2024 / Biotricity Inc. , a leading medical diagnostic and consumer healthcare technology company, today announced
- 2y agoBTCYBTTXBetter Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVACCESS NewswireORLANDO, FL / ACCESSWIRE / March 1, 2024 / RedChip Companies will air interviews with Better Therapeutics, Inc. and Biotricity, Inc. on the RedChip Small Stocks, Big Money™ show, a
- 2y agoBTCYBiotricity Receives Health Canada Clearance for BiotresACCESS NewswireWell Positioned to Enter US $1.56 Billion Canadian Cardiology Devices MarketREDWOOD CITY, CA / ACCESSWIRE / February 29, 2024 / Biotricity Inc. , a leading
- 2y agoBTCYBiotricity, Inc. (BTCY) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoBTCYBiotricity Strengthens its Foundation for Growth, Achieves Lower Cost of Sales, Expanding Margins of 73% and Increased Device Sales, for Third Quarter of Fiscal Year 2024ACCESS NewswireTopline growth with better quality revenue mixIncrease in subscription revenue vs usage based revenue , reducing seasonality impact with more predictable revenueImproved marginsLower costs with improved
- 2y agoBTCYBiotricity to Host Third Quarter Fiscal Year 2024 Financial Results and Business Update Call on February 21stACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / February 19, 2024 / Biotricity Inc. , a Technology-as-a-Service company operating in the remote cardiac monitor
- 2y agoBTCYBiotricity Advances Towards Breakeven Milestone - Set to Announce Record Margins and Operational Efficiency for Third Quarter of Fiscal Year 2024ACCESS NewswireCompany continues its shift to subscription-based revenue, prioritizing margin improvement and operational efficiency enhancements, on the path to breakevenManagement to announce Third Quarter Fiscal 2024 Results at
- 2y agoBTCYBiotricity Expands Development of its Cardiac AI Cloud Platform with Data Ecosystem of over 360 billion HeartbeatsACCESS NewswireCompany's growing data ecosystem supports the development of large data models for its future predictive technologies and Cardiac AI cloud platformCompany has analyzed over 360 Billion heartbeats and helped diagnose over
- 2y agoBTCYBiotricity Delivers Record Margins and Double Digit Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2024ACCESS NewswireCompany reports Q2-FY24 revenue grew by 21.4% YOY to $2.9 million; continuing to advance toward positive cashflowRecurring technology fees, customer device sales, remain on an upward trendReduced SG&A to $3.5
- 3y agoBTCYBiotricity to Host Second Quarter Fiscal Year 2024 Financial Results and Business Update Call on November 14thACCESS NewswireBiotricity improves margins while lowering selling expenses and operating lossesREDWOOD CITY, CA / ACCESSWIRE / November 10, 2023 / Biotricity Inc. , a
- 3y agoBTCYBiotricity Releases Another Groundbreaking Product: Biotres ProACCESS NewswireCompany further expands its current product portfolio, making it the most comprehensive Remote Patient and Cardiac Monitoring portfolio globally.Company developed Biotres Pro with critical capability of cellular backup
- 3y agoSWKHBIOLBTCYELUT+1SWK Holdings Highlights Recent Achievements and Provides Portfolio UpdatePR NewswireSWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and mid-sized...
- 3y agoBTCYBiotricity Continues to Expand Patent Portfolio with Latest Patent Filing for Bioheart DeviceACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / October 10, 2023 / Biotricity, Inc. , a Technology-as-a-Service company operating in the remote cardiac monitoring sector of consumer healthcare, today announced its
- 3y agoBTCYCORRECTION BY SOURCE: Biotricity Announces Patent Filing for Cutting-Edge Biotres DeviceACCESS NewswireThis release corrects and replaces the headline in the the release that was disseminated October 3, 2023.The reason for this correction is to fix the title which previously stated "patient" rather than the